Drug details
Refacto (antihemophilic factor)
type of
ReFacto (antihemophilic factor, recombinant) is a protein used to treat or prevent bleeding episodes in adults and children with hemophilia A. ReFacto is also used to control bleeding related to surgery or dentistry in a person with hemophilia, and to prevent joint damage in people age 16 or older with severe hemophilia A and no prior joint damage. ReFacto is not for use in people with von Willebrand disease. ReFacto is available in generic form.
This drug may have the following side effects:
- sore throat
- redness
- itching
- cough
- stinging
- runny nose; fever or chills; mild nausea
- vomiting; unusual or unpleasant taste in your mouth; skin itching or rash; warmth
- pain,or
- irritation where the injection was given
The following drugs are related to Refacto, either as a replacement or used together:
- Advate ([antihemophilic factor (recombinant), plasma/albumin-free method] for intravenous injection)
- Kogenate FS (antihemophilic factor (recombinant))
- Kovaltry (antihemophilic factor (recombinant) for intravenous administration)
- Novoeight (antihemophilic factor (recombinant) lyophilized powder for intravenous injection)
- Eloctate (antihemophilic factor (recombinant), fc fusion protein for intravenous infusion)
- Rixubis (coagulation factor ix (recombinant) for intramuscular injection)
- Esperoct ([antihemophilic factor (recombinant), glycopegylated-exei] injection)